153 related articles for article (PubMed ID: 10741719)
1. 1-phenyl-2-decanoylamino-3-morpholino-1-propanol chemosensitizes neuroblastoma cells for taxol and vincristine.
Sietsma H; Veldman RJ; Kolk D; Ausema B; Nijhof W; Kamps W; Vellenga E; Kok JW
Clin Cancer Res; 2000 Mar; 6(3):942-8. PubMed ID: 10741719
[TBL] [Abstract][Full Text] [Related]
2. P-glycoprotein modulates ceramide-mediated sensitivity of human breast cancer cells to tubulin-binding anticancer drugs.
Shabbits JA; Mayer LD
Mol Cancer Ther; 2002 Jan; 1(3):205-13. PubMed ID: 12467215
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of glycolipid biosynthesis inhibitors on ceramide-induced cell death in neuroblastoma cells.
Bieberich E; Freischütz B; Suzuki M; Yu RK
J Neurochem; 1999 Mar; 72(3):1040-9. PubMed ID: 10037475
[TBL] [Abstract][Full Text] [Related]
4. The glucosylceramide synthase inhibitor PDMP sensitizes pancreatic cancer cells to MEK/ERK inhibitor AZD-6244.
Wang T; Wei J; Wang N; Ma JL; Hui PP
Biochem Biophys Res Commun; 2015 Jan; 456(3):821-6. PubMed ID: 25498501
[TBL] [Abstract][Full Text] [Related]
5. D,L-Threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol (DL-PDMP) increases endoplasmic reticulum stress, autophagy and apoptosis accompanying ceramide accumulation via ceramide synthase 5 protein expression in A549 cells.
Yamane M; Miyazawa K; Moriya S; Abe A; Yamane S
Biochimie; 2011 Sep; 93(9):1446-59. PubMed ID: 21571032
[TBL] [Abstract][Full Text] [Related]
6. D-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol alters cellular cholesterol homeostasis by modulating the endosome lipid domains.
Makino A; Ishii K; Murate M; Hayakawa T; Suzuki Y; Suzuki M; Ito K; Fujisawa T; Matsuo H; Ishitsuka R; Kobayashi T
Biochemistry; 2006 Apr; 45(14):4530-41. PubMed ID: 16584188
[TBL] [Abstract][Full Text] [Related]
7. Differential chemosensitizing effect of two glucosylceramide synthase inhibitors in hepatoma cells.
di Bartolomeo S; Spinedi A
Biochem Biophys Res Commun; 2001 Oct; 288(1):269-74. PubMed ID: 11594784
[TBL] [Abstract][Full Text] [Related]
8. Influence of ceramide metabolism on P-glycoprotein function in immature acute myeloid leukemia KG1a cells.
Plo I; Lehne G; Beckstrøm KJ; Maestre N; Bettaïeb A; Laurent G; Lautier D
Mol Pharmacol; 2002 Aug; 62(2):304-12. PubMed ID: 12130682
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of glycosphingolipid biosynthesis by L-threo-1-phenyl-2-decanoylamino-1-propanol and its homologs in B16 melanoma cells.
Inokuchi J; Usuki S; Jimbo M
J Biochem; 1995 Apr; 117(4):766-73. PubMed ID: 7592537
[TBL] [Abstract][Full Text] [Related]
10. Abrogation of shedding of immunosuppressive neuroblastoma gangliosides.
Li R; Ladisch S
Cancer Res; 1996 Oct; 56(20):4602-5. PubMed ID: 8840970
[TBL] [Abstract][Full Text] [Related]
11. Induction of ganglioside biosynthesis and neurite outgrowth of primary cultured neurons by L-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol.
Usuki S; Hamanoue M; Kohsaka S; Inokuchi J
J Neurochem; 1996 Nov; 67(5):1821-30. PubMed ID: 8863486
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of [(3)H]thymidine transport is a nonspecific effect of PDMP in primary cultures of mouse epidermal keratinocytes.
Griner RD; Bollag WB
J Pharmacol Exp Ther; 2000 Sep; 294(3):1219-24. PubMed ID: 10945880
[TBL] [Abstract][Full Text] [Related]
13. L-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol stimulates ganglioside biosynthesis, neurite outgrowth and synapse formation in cultured cortical neurons, and ameliorates memory deficits in ischemic rats.
Inokuchi J; Kuroda Y; Kosaka S; Fujiwara M
Acta Biochim Pol; 1998; 45(2):479-92. PubMed ID: 9821877
[TBL] [Abstract][Full Text] [Related]
14. Induction of glucosylceramide synthase by synthase inhibitors and ceramide.
Abe A; Radin NS; Shayman JA
Biochim Biophys Acta; 1996 Feb; 1299(3):333-41. PubMed ID: 8597588
[TBL] [Abstract][Full Text] [Related]
15. Effects of an inhibitor of glucosylceramide synthase on glycosphingolipid synthesis and neurite outgrowth in murine neuroblastoma cell lines.
Uemura K; Sugiyama E; Taketomi T
J Biochem; 1991 Jul; 110(1):96-102. PubMed ID: 1834639
[TBL] [Abstract][Full Text] [Related]
16. Synergistic cytotoxicity in solid tumor cell lines between N-(4-hydroxyphenyl)retinamide and modulators of ceramide metabolism.
Maurer BJ; Melton L; Billups C; Cabot MC; Reynolds CP
J Natl Cancer Inst; 2000 Dec; 92(23):1897-909. PubMed ID: 11106681
[TBL] [Abstract][Full Text] [Related]
17. Effect of an inhibitor of glucosylceramide synthesis on cultured rabbit skin fibroblasts.
Uemura K; Sugiyama E; Tamai C; Hara A; Taketomi T; Radin NS
J Biochem; 1990 Oct; 108(4):525-30. PubMed ID: 2149853
[TBL] [Abstract][Full Text] [Related]
18. PDMP sensitizes neuroblastoma to paclitaxel by inducing aberrant cell cycle progression leading to hyperploidy.
Dijkhuis AJ; Klappe K; Jacobs S; Kroesen BJ; Kamps W; Sietsma H; Kok JW
Mol Cancer Ther; 2006 Mar; 5(3):593-601. PubMed ID: 16546973
[TBL] [Abstract][Full Text] [Related]
19. 1-phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP) facilitates curcumin-induced melanoma cell apoptosis by enhancing ceramide accumulation, JNK activation, and inhibiting PI3K/AKT activation.
Yu T; Li J; Qiu Y; Sun H
Mol Cell Biochem; 2012 Feb; 361(1-2):47-54. PubMed ID: 21959977
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of glucosylceramide synthase does not reverse drug resistance in cancer cells.
Norris-Cervetto E; Callaghan R; Platt FM; Dwek RA; Butters TD
J Biol Chem; 2004 Sep; 279(39):40412-8. PubMed ID: 15263008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
